China Kanghui Holdings, an orthopedic implant maker, reported Q2 revenues of 39 million RMB ($8.6 million), an increase of 29%. Net income grew by 36% to 28 million RMB ($4.1 million), pegging the company’s net margins at an impressive 48%. The results are preliminary. Late last month, Kanghui signaled its intention to stage an IPO on the New York Stock Exchange. More details....